No se han estudiado la incidencia de efectos adversos a largo plazo, a parte de que en la mayora de los pacientes, el efecto beneficioso va mermndose con el tiempo
The lack of significant mean difference, despite a trend toward GSH-deficit in schizophrenia, compared to the two prior meta-analyses (7, 12) relates to several recent studies that failed to demonstrate a group difference for patients vs
On average, people lose a significant amount of weight
The Ozempic and Mounjaro group of drugs can be life-changing for many who are prescribed these medications, but also come with risks and side effects that can lead to severe and in the most extreme cases, life-threatening, issues
Patients should discuss their weight loss goals and expectations with their healthcare provider to ensure that they are on track to achieve the desired outcomes